AdaptHealth Corp. (NASDAQ:AHCO) Stake Raised by Northern Trust Corp

Northern Trust Corp increased its holdings in AdaptHealth Corp. (NASDAQ:AHCO) by 11.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,172,265 shares of the company’s stock after acquiring an additional 116,981 shares during the period. Northern Trust Corp owned about 0.87% of AdaptHealth worth $11,160,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of AHCO. Barclays PLC lifted its stake in AdaptHealth by 361.3% in the 3rd quarter. Barclays PLC now owns 181,240 shares of the company’s stock worth $2,034,000 after acquiring an additional 141,949 shares in the last quarter. Franklin Resources Inc. lifted its stake in AdaptHealth by 20.2% in the 3rd quarter. Franklin Resources Inc. now owns 65,601 shares of the company’s stock worth $737,000 after acquiring an additional 11,037 shares in the last quarter. JPMorgan Chase & Co. lifted its stake in AdaptHealth by 73.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 191,833 shares of the company’s stock worth $2,154,000 after acquiring an additional 81,097 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management raised its stake in shares of AdaptHealth by 15.4% during the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company’s stock worth $121,000 after purchasing an additional 1,690 shares in the last quarter. Finally, Blue Trust Inc. raised its stake in shares of AdaptHealth by 24.1% during the 4th quarter. Blue Trust Inc. now owns 5,746 shares of the company’s stock worth $55,000 after purchasing an additional 1,115 shares in the last quarter. 82.67% of the stock is owned by hedge funds and other institutional investors.

AdaptHealth Stock Down 0.2%

Shares of AHCO stock opened at $9.02 on Friday. The stock’s 50 day simple moving average is $9.14 and its 200 day simple moving average is $9.68. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. AdaptHealth Corp. has a twelve month low of $7.11 and a twelve month high of $11.90. The company has a market capitalization of $1.22 billion, a price-to-earnings ratio of -5.47, a PEG ratio of 1.08 and a beta of 1.64.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on AHCO. Canaccord Genuity Group raised their price target on AdaptHealth from $13.00 to $14.00 and gave the stock a “buy” rating in a research note on Wednesday, February 26th. UBS Group cut their price target on AdaptHealth from $12.00 to $11.00 and set a “buy” rating for the company in a research note on Thursday, February 13th. Royal Bank of Canada cut their price target on AdaptHealth from $14.00 to $13.00 and set an “outperform” rating for the company in a research note on Thursday, May 8th. Robert W. Baird raised their price target on AdaptHealth from $14.00 to $16.00 and gave the stock an “outperform” rating in a research note on Thursday, February 27th. Finally, Truist Financial cut their price target on AdaptHealth from $14.00 to $13.00 and set a “buy” rating for the company in a research note on Monday, May 12th. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $13.40.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.